Loading stock data…
PAHC
$32.65+0.89 (+2.80%)
After Hours$32.65+0.00 (+0.00%)· Last close Jun 9
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Phibro Animal Health Corporation in the Healthcare sector is trading at $32.65. Wall Street consensus targets $45.60 (5 analysts), implying a +39.7% move over the next 12 months. The stock is currently 46% below its 52-week high of $60.08, remaining 24.5% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +39.7% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$32.65
Potential Downside
0%
Whystock Fair Value$32.65
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mine...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
1.47%
ROE
Elite ROE. Management converts capital into profit efficiently.
26.32%
Volume
Today's trading volume
206,327
Recent News
How The Story Is Shifting For Phibro Animal Health (PAHC) As Analysts Reset Fair Value
The latest analyst update trims Phibro Animal Health’s assessed fair value from US$48.50 to US$45.60, bringing it closer to a cluster of price targets around US$44 to US$45.60. This shift aligns with more cautious commentary around regulatory risks and how the stock compares with peers. Read on to see what this may mean for you and how to keep track of the evolving analyst story around Phibro Animal Health. Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other...
1 Growth Stock with All-Star Potential and 2 We Question
Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.
Why Phibro Animal Health (PAHC) Stock Is Trading Up Today
Shares of animal health products manufacturer Phibro Animal Health (NASDAQ:PAHC) jumped 10.2% in the afternoon session after a director, E. Thomas Corcoran, purchased $317,700 worth of company stock.
PAHC vs. SYK: Which Stock Should Value Investors Buy Now?
PAHC vs. SYK: Which Stock Is the Better Value Option?
3 Profitable Stocks That Fall Short
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.